Introduction-Diabetes is one of the most common and fastest-growing comorbidities of pregnancy. Temporal trends in gestational diabetes mellitus (GDM) have not been examined at the state level. This study examines GDM prevalence trends overall and by age, state, and region for 19 states, and by race/ethnicity for 12 states. Sub-analysis assesses trends among GDM deliveries by insurance type and comorbid hypertension in pregnancy.
Introduction
Diabetes is one of the most common and fastest-growing comorbidities of pregnancy. 1, 2 Gestational diabetes mellitus (GDM), defined as diabetes first diagnosed during pregnancy, has been associated with numerous adverse perinatal outcomes such as macrosomia, or larger-than-normal babies, 3 which leads to difficult labor and delivery 4 and maternal morbidity. 5 The risk of developing GDM is increased in women with the following risk factors: age >25 years, non-white race, family history of diabetes, 6 GDM in a previous pregnancy, chronic hypertension, 7 high BMI, large abdominal circumference, high fasting glycemia in the first trimester of pregnancy, and the presence of polycystic ovary syndrome. 8 Further, women who suffer from GDM as well as their offspring are also at higher risk for developing type 2 diabetes later in life. 9 Consequently, pregnancies complicated by GDM need to be monitored closely for obstetric complications and adverse mother and infant outcomes.
In a previous study, analyses found that GDM rates differ by state; the variation was attributable to differences in obesity at the population level, age, race/ethnicity, hospital status, and health insurance status. 10 Information on trends at the state level is needed to plan and focus healthcare services as well as to develop effective healthcare practices and policies for diabetes prevention and control. However, data on population-based, statespecific trends in GDM prevalence are limited. For states with available data, trends were assessed from 2000 through 2010 in GDM deliveries overall and by state, age, and race or ethnicity. Secondary analyses were conducted within the population of GDM deliveries to assess trends in GDM deliveries with comorbidities such as pre-eclampsia and prepregnancy hypertension, and funding of GDM deliveries by type of health insurance.
Methods

Study Sample
Data were used from the 2000-2010 State Inpatient Databases (SID), sponsored by the Agency for Healthcare Research and Quality to identify hospital discharges involving diabetes diagnosed during pregnancy. 11 The databases contain information on hospital inpatient stays from all community hospitals in states participating in the Healthcare Cost and Utilization Project (HCUP) and are largely a census rather than a sample of those hospitals; they account for approximately 86% of hospitalizations nationally. Annual data collection by the databases includes the 19 participating states with data from 2000 through 2010: Arizona, California, Colorado, Florida, Hawaii, Iowa, Kentucky, Massachusetts, Maryland, Michigan, North Carolina, New Jersey, New York, Oregon, South Carolina, Utah, Washington, Wisconsin, and West Virginia.
Community hospitals are defined as short-term, nonfederal, general, and other hospitals, excluding hospital units of other institutions (e.g., prisons). 12 Community hospitals (and HCUP data) include obstetrics-gynecology, ear-nose-throat, orthopedic, cancer, pediatric, public (e.g., county hospitals), and academic medical hospitals (e.g., university hospitals). Some states exclude hospitals that mainly focus on long-term care or psychiatric, alcoholism, or chemical-dependency treatment, although discharges from units of these types that are part of community hospitals are included. Although not all states include these types of hospitals, the numbers of deliveries from them are few; therefore, any differences in the population of deliveries would be minimal.
Hospital delivery discharge codes were identified using ICD-9-CM diagnosis codes or diagnosis-related group (DRG) codes. DRGs comprise a patient classification system that categorizes hospital stays into groups that are clinically similar with respect to resource use, including diagnosis and type of treatment or procedure. Each hospital stay has one DRG assigned to it. Delivery stays were identified by discharges having a DRG Deliveries were identified with a GDM diagnosis by the presence of ICD-9-CM codes 648.8x listed anywhere on the discharge record. Cases that listed both codes for GDM and for pre-pregnancy diabetes were excluded (n=7,725; <1%).
Measures
Examined variables included maternal age; race/ethnicity; expected primary health insurance; and two associated comorbidities, pre-eclampsia and pre-pregnancy hypertension. 13 listed anywhere on the discharge record. Medicaid and Medicare were combined, though deliveries expected to be funded by Medicare comprised only about 1% of the total. Pre-pregnancy BMI was not available on maternal hospital discharges and therefore was not included. Data were not reported for California in 2002 or for Hawaii in 2005, and seven states did not report race or ethnicity during the entire study period (Iowa, Kentucky, North Carolina, Oregon, Utah, Washington, and West Virginia).
Statistical Analysis
Age-standardized rates of GDM were estimated for each state, region, and the selected subgroups, using the national number of deliveries from 2000 (i.e., the Nationwide Inpatient Sample [NIS] from HCUP) for age standardization. For the 12 states with race/ethnicity, age-and race-standardized rates were computed using data from the 2000 NIS. A subanalysis was also conducted to assess trends within the population of GDM deliveries. Those analyses included assessing trends among women with GDM in comorbidities such as pre-eclampsia and pre-pregnancy hypertension as well as changes in funding of GDM deliveries by insurance type. SAS, version 9.3, and SUDAAN, version 11.0.0, were used for data management and analyses to produce estimates. The number of deliveries was obtained by DRG codes from the HCUPnet online query system 11 for California in 2002 and Hawaii in 2005, and, using PROC MI in SAS, all variables were imputed for those years based on data (e.g., race/ethnicity, age, GDM, pre-pregnancy diabetes status, insurance type, preeclampsia, pre-pregnancy hypertension) from other years within the same state. Less than 1% of data were missing for variables other than race/ethnicity for the rest of the states and years but, for consistency, those were also imputed. The one exception was among the 12 states reporting race and ethnicity: race and ethnicity were missing on average 26.2% per year and were imputed from available data in the same state. Potential bias due to the large proportion with missing race was assessed with a sensitivity analysis comparing complete case rates of GDM deliveries with imputed rates. General linear regression with a log-link and binomial distribution was used in 2014 to assess the annual change over 11 years from 2000 through 2010 and to test for a statistically significant change in prevalence over time. Because the change in total number of deliveries is informative about the change in GDM prevalence over time, statistically significant annual changes in total number of deliveries by characteristics assessed are presented. For example, if GDM prevalence is increasing significantly, knowing whether the total number of deliveries dropped, remained constant, or increased in relation to increase in GDM deliveries is more informative than only reporting change in GDM prevalence. This study was reviewed by the Human Subjects Coordinator at CDC and, as an analysis of secondary data without identifiers, was determined to be exempt from IRB review.
Results
Overall, the age-standardized prevalence of GDM deliveries in the 19 states increased significantly from 3.71 in 2000 to 5.77 per 100 deliveries in 2010 (relative change, 56%; annual change, p < 0.01) ( Table 1 ). The greatest relative increase was seen in Utah (1.95 to 3.66 per 100 deliveries; relative increase, 88%); the smallest increase was seen in Maryland (4.26 to 5.80 per 100 deliveries; relative increase, 36%). In the last 2 years, four of the five states with the highest prevalence of GDM (≥6.00 per 100 births) were in the Western region, including California, Oregon, Washington, and Hawaii. The four regional trends of GDM prevalence increased significantly as well (p < 0.001). The Midwestern and Western regions increased more (relative increases of 69% and 64%, respectively) than the Northern and Southern regions (relative increases of 44% and 47%, respectively).
GDM rates for all age groups in all 19 states increased significantly (p < 0.01) ( Table 2) . The greatest relative increase in GDM deliveries occurred among those aged 15-24 years (range, 59%-66%). Among age groups, the absolute increase in GDM deliveries followed a dose response, increasing with older age.
GDM among deliveries increased significantly (p < 0.01) among all race/ethnicity groups in the 12 states reporting race and ethnicity, with the highest relative increase in Hispanics (66%). Yet, throughout the study time period, NH Asians had the highest prevalence of GDM (range, 6.48%-10.27%). Age-and race-standardized GDM rates were consistently higher than crude GDM rates in these 12 states (Figure 1 ). Complete case rates of GDM deliveries were consistently lower than imputed rates for all race/ethnicity groups. This difference was nearly identical for NH whites, Hispanics, and NH Asians (within 9% on average). For NH blacks, the complete case rates were much closer to the imputed rates (within <1% on average).
From 2000 through 2010, among GDM deliveries, the proportion with comorbidities increased significantly: pre-pregnancy hypertension from 2.5% to 4.1% (relative increase, 64%) and pre-eclampsia from 9.8% to 11.0% (relative increase, 12%) (Figure 2 ). The prevalence of Medicaid/Medicare funding of GDM deliveries increased from 37.6% to 50.8% (absolute increase, 13.2 percentage points) (p < 0.01), and the prevalence of private insurers funding GDM deliveries decreased from 57.5% to 44.0% (absolute decrease, 13.5 percentage points) (p < 0.01) (Figure 3 ).
The number of GDM deliveries increased significantly (p < 0.001) from 75,212 in 2000 to 119,229 in 2010 in the 19 states (relative increase, 59%). Over the 11-year period, significant increases (p < 0.05) in the total number of deliveries occurred among women aged 25-29 years (relative increase, 3%) and 40-44 years (relative increase, 19%); Hispanic (relative increase, 18%) and NH Asian/Pacific Islander women (relative increase, 32%); and deliveries with Medicare/Medicaid (relative increase, 31%). Conversely, statistically significant decreases occurred in the total number of deliveries among NH whites (relative decrease, 11%) and women with private insurance (relative decrease, 24%).
Discussion
The results of this study suggest that GDM delivery rates increased across all demographic groups (e.g., age, race/ethnicity). State and regional differences in GDM prevalence may reflect race and ethnicity differences in deliveries overall. Western states had the highest prevalence of GDM deliveries and also had the highest proportion of Asians. 14 Throughout the study period, the highest rates of GDM were found among NH Asian and Pacific Islander women. Studies have shown that even at normal or low BMI, Asians have much higher risk of GDM compared with their NH white counterparts. 15 Notably, the rate of GDM in NH Asian women is increasing more because of the much faster pace of increase in GDM deliveries (numerator) compared with that of the total deliveries (denominator), as the latter has also increased significantly.
Among the 12 states, with race/ethnicity, the age-and race-standardized rates were consistently higher than the crude rates, probably because of higher prevalence among older and non-white women. The highest relative increase in GDM by race/ethnicity was among Hispanics and may be related to increases in obesity prevalence during 1999-2008, which were greater among Mexican American women aged 20-39 years (from 30.6% to 39.6%) compared to black women (from 46.2% to 47.2%) and white women (from 28.4% to 34.0%). 16 Also, the greatest absolute increase in GDM was in the West, the region with the highest proportion of Hispanics in 2010 (28.6%). 17 The annual increase in number of deliveries (denominator) was statistically significant among Hispanic women, meaning that the increase in GDM among Hispanic women (numerator) was even greater than the increase in deliveries.
GDM deliveries have become more complicated as those with comorbidities such as prepregnancy hypertension and pre-eclampsia have increased. Pre-eclampsia is a leading cause of maternal and perinatal mortality and morbidity, 18 and hypertensive disorders during pregnancy are major contributors to prematurity, small-for-gestational-age status, poor Apgar scores, C-sections, stillbirths, and early neonatal deaths. 19 In addition, both the mother and infant are at increased risk for future cardiovascular disease and type 2 diabetes. 20 GDM disproportionately burdens those with lower SES, 21 and this may add to demands on publicly funded healthcare programs. Throughout the study period, the proportion of GDM deliveries funded by Medicaid/Medicare increased significantly. In addition, the annual increase in the number of deliveries funded by Medicaid/Medicare (denominator) was statistically significant; this means that the increase in GDM publicly funded deliveries (numerator) was even greater than the increase in the number of deliveries among women on Medicaid/Medicare. Starting in 1991, all state Medicaid programs were required to cover pregnant women with incomes <133% of the federal poverty level. 22 Since 2000, there was a shift in GDM deliveries from being funded by private insurance to being funded by Medicaid/Medicare. The increase in GDM deliveries with comorbid conditions will likely impact the cost to insurers, and this may be an important area for further research. This study's strengths include data that were population-based, available at a state level, and reflected trends over an 11-year period. Although all states were not represented and, therefore, results could not be generalized to the U.S., each region of the country was represented by at least three states. We are aware of no data source that covers all states for state-specific estimates.
Limitations
This study was subject to several limitations. One limitation was inconsistent availability of race/ethnicity data both across and within states, meaning that GDM rates for race and ethnicity do not represent the 19 states in the entire study population. However, sensitivity analyses suggest conclusions would not have changed. Also, Indian Health Services hospitals are not included in the SID; thus, the sample of Native Americans' deliveries in community hospitals was too small to report.
Variability in GDM rates may reflect reporting artifacts and the extent to which screening for GDM occurs, as rates of screening and reporting likely vary by type of health insurance and hospital characteristics. Further, screening recommendations for GDM changed during the study, and no data regarding screening practices were available.
No data on pre-pregnancy weight or BMI were available. One study found that for certain race/ethnicity groups, as many as 60% of GDM cases could be prevented if women entered pregnancy at a normal, healthy weight. 23 In addition, women who are obese are four to eight times more likely to develop GDM. 24 Therefore, the increasing prevalence of GDM in this study was likely strongly associated with rising levels of obesity during this period. Further, because ICD diagnosis codes were used, it was unclear whether increases could have been attributable in part to improved assessment or been driven by greater prevalence of underlying risk factors for GDM.
Finally, using ICD codes may have resulted in underestimation of GDM prevalence and complications such as hypertension in deliveries. One study found that using ICD codes for hypertension in deliveries had sensitivity as low as 58%. 25 This study found that fewer than 2% of all deliveries were reported to be affected by hypertension, though one study reported that hypertension occurs in 5%-10% of pregnancies. 26 
Conclusions
Contributions of this study include the findings that GDM prevalence increased across demographic groups, and the proportion of GDM deliveries complicated by pre-pregnancy hypertension also increased. This clinical combination places children of mothers with GDM at risk for serious adverse outcomes. This study also found that the burden of funding GDM deliveries shifted from private insurance to public payers during the examined time period.
Effective diabetes prevention and control strategies for women of childbearing age can help to protect the health of women and their newborns. Structured lifestyle changes or pharmaceutical interventions can prevent or delay type 2 diabetes among women with a history of GDM, 27 and these interventions can start before and during pregnancy. 28 Breastfeeding also may mitigate the risk of developing type 2 diabetes for mothers, particularly those who are obese or who have GDM, and for their offspring as they grow into adulthood. 29, 30 
